A New Weight-Loss Drug Just Outperformed Popular GLP-1s. Here’s What It Means for the Future of Health
RSS SUMMARY · AGGREGATED FROM INC
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
Continue Reading
The full story continues on Inc..
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
INC
Business
Apple’s New Ad Is a Brutal Jab at Google Chrome and Its Privacy Policies
INC·2h ago·3 min read
Business
After the Collapse of Spirit Airlines, This Major Budget Carrier Just Became the Target of a $4.1 Billion Takeover
INC·5h ago·3 min read
Business
How a Biotech Startup Is Using Dogs and AI to Rewrite the Rules of Cancer Screening
INC·5h ago·3 min read
Business
The Unicorn Trap: How a $1 Billion Valuation Just Became a Startup’s Worst Nightmare
INC·4h ago·3 min read
Related
On this beat
Business
Morgan Stanley sees major upside for Apple stock ahead of WWDC
THE STREET·38m ago·3 min read
Business
Chevron CEO sends blunt message on oil, the economy
THE STREET·1h ago·3 min read
Business
SpaceX stock market debut set to make Elon Musk a trillionaire
SKY NEWS·2h ago·3 min read
Business
Apple’s New Ad Is a Brutal Jab at Google Chrome and Its Privacy Policies
INC·2h ago·3 min read